🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Proposed is a parallel-design randomized controlled trial to compare the ef...
Status
Completed
Location
Yale-Griffin Prevention Research Center
Start Date
2012-04
Trial ID
NCT02050165
Treatments Being Tested
Evaluate the efficacy, safety and tolerability of a single intraoperative d...
Status
Terminated
Location
Alabama Clinical Therapeutics, LLC
Start Date
2007-09
Trial ID
NCT00683267
Treatments Being Tested
This study is a Phase I, single-center, randomized, double-blind, placebo-c...
Status
Completed
Location
SGS clinical pharmacology unit
Start Date
2016-10-18
Trial ID
NCT03102567
This study hypothesizes that electroacupuncture combined with self-administ...
Status
Recruiting
Location
Qinghai University Affiliated Hospital
Start Date
2024-10-08
Trial ID
NCT06602167
This is a phase II, observer-blind, multiple-centre, randomized, placebo-co...
Status
Terminated
Location
Changhua Christian Hospital
Start Date
2021-01-30
Trial ID
NCT04773067
The aim of this study is to test whether when using the Vestibular Rehabili...
Status
Completed
Location
University of Kansas Medical Center
Start Date
2022-05-23
Trial ID
NCT05436067
Treatments Being Tested
Motor fluctuations are identified as the most challenging symptoms by parki...
Status
Not Yet Recruiting
Location
CHU Toulouse
Start Date
2025-05-01
Trial ID
NCT06817200
Treatments Being Tested
An Advanced Virtual Exercise Environment Device (AVEED) has been developed ...
Status
Completed
Location
Univerisity of Alabama at Birmingham
Start Date
2017-02-10
Trial ID
NCT02990507
This is a randomized, double blinded, standard of care controlled clinical ...
Status
Completed
Location
Henry Ford Hospital
Start Date
2016-04
Trial ID
NCT02740192
Treatments Being Tested
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested